(Q35855002)

English

The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia

scientific article published in August 2004

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

1 reference

Europe PubMed Central

The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

object named as

Serenoa repens

1 reference

based on heuristic

inferred from title

author name string

Glenn S Gerber

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

John M Fitzpatrick

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

94

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

338-344

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Sexual dysfunction in men with lower urinary tract symptoms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04962.X

21 January 2018

Tamsulosin: 3-year long-term efficacy and safety in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction: analysis of a European, multinational, multicenter, open-label study. European Tamsulosin Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04962.X

21 January 2018

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04962.X

21 January 2018

Effect of the lipidosterolic extract of Serenoa repens (Permixon) and its major components on basic fibroblast growth factor-induced proliferation of cultures of human prostate biopsies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04962.X

21 January 2018

Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04962.X

21 January 2018

A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04962.X

21 January 2018

Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04962.X

21 January 2018

Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04962.X

21 January 2018

Meta-analysis of randomized trials of terazosin in the treatment of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04962.X

21 January 2018

Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04962.X

21 January 2018

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04962.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2004.04962.X

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35855002&oldid=1862020248"